Director/PDMR Shareholding

Summary by AI BETAClose X

Close Brothers Group plc announced that Non-Executive Director Sally Williams purchased 6,914 ordinary shares on April 8, 2026, on the London Stock Exchange for an aggregated price of £4.553 per share, with individual transactions at £4.548 for 2,514 shares and £4.556 for 4,400 shares. Additionally, Non-Executive Director Mark Pain purchased 4,476 ordinary shares at £4.49 each, and Catherine Pain, a person closely associated with Mark Pain, purchased 4,422 ordinary shares at the same price of £4.49 each, both on April 8, 2026, on the London Stock Exchange.

Disclaimer*

Close Brothers Group PLC
09 April 2026
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Sally Williams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Close Brothers Group plc

b)

 

LEI

 

 

213800W73SYHR14I3X91

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 25p each

 

 

 

GB0007668071

 

b)

 

Nature of the transaction

 

 

Purchase of 6,914 ordinary shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£4.548

2,514

£4.556

4,400

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

6,914

 

 

£4.553

 

e)

 

Date of the transaction

 

 

8 April 2026

f)

 

Place of the transaction

 

 

London Stock Exchange, XLON

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1.   Mark Pain

2.   Catherine Pain

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1.   Non-Executive Director

2.   Person closely associated to PDMR, Mark Pain

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Close Brothers Group plc

b)

 

LEI

 

 

213800W73SYHR14I3X91

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 25p each

 

 

 

GB0007668071

 

b)

 

Nature of the transaction

 

 

1.   Purchase of 4,476 ordinary shares

2.   Purchase of 4,422 ordinary shares

 

c)

 

Price(s) and volume(s)

 

 

 

1.   Mark Pain

 

Price(s)

 

Volume(s)

£4.49

4,476

 

 

2.   Catherine Pain

 

Price(s)

 

Volume(s)

£4.49

4,422

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

N/A Single Transaction

 

e)

 

Date of the transaction

 

 

8 April 2026

f)

 

Place of the transaction

 

 

London Stock Exchange, XLON

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings